Off Patent
October 2027

Amitiza

lubiprostone

Sucampo Pharma Americas LLC

Capsule (oral) · NDA 021908

Last listed protection ends
October 25, 2027

The FDA lists 3 patents for Amitiza, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 8,338,639
    Claims the drug product
  2. Patent 8,779,187
    Claims the drug product
  3. Patent 8,026,393
    Claims the drug product